Company intelligence / Profile preview

上智投顧

Ownership: Private
Development stage: Other

Overview

上智投顧 is an active Taiwanese venture capital/investment advisory firm that invests in high-value industries including biotechnology and pharmaceuticals. It does not itself conduct drug discovery, development, manufacturing, or commercialization. Instead, it provides funding to other companies within these sectors. There are no indications that it operates as a platform company nor that it develops its own therapeutic programs. No clinical pipeline exists under this entity's name—it serves solely as an investor/advisor within the broader life sciences ecosystem[1].

Industry: Investors

Partnerships

As an investor, it has participated in funding rounds for various Taiwanese biotech companies[1]

Beyond the preview

Go deeper on 上智投顧.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 上智投顧.

Explore the full profile